Teiko.bio

NK Cell Therapy Consortium

The first Natural Killer consortium dedicated to accelerating development of engineered NK cell therapies through our comprehensive 44-marker high-resolution panel for NK cellular profiling
search icon

Source identification

Profile over 1T marker combinations to select ideal donor and source material based on NK receptor profile

 

branching icon

Process optimization

Increase yield, shorten turnaround, and improve final product with data-driven insights at every stage of the process

 

group of hexagons icon

Clinical profiling

Disentangle the role of your therapy vs patient NK cells in response and identify optimal combination strategies to improve efficacy